Stock comparison
Eli Lilly
West Pharmaceutical Services
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
WST
West Pharmaceutical Services
Market cap
$21.21B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | WST | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 55C | LLY |
| Benjamin Graham | 76B | 80A | WST |
| Philip Fisher | 75B | 39D | LLY |
| Peter Lynch | 64C | 16F | LLY |
| Joel Greenblatt | 68B | 52C | LLY |
| Charlie Munger | 75B | 52C | LLY |
| Terry Smith | 66B | 46D | LLY |
Side-by-side metrics
| Metric | LLY | WST |
|---|---|---|
| Market cap | $946.37B | $21.21B |
| P/E (TTM) | 35.6x | 39.8x |
| EV/EBIT | 33.2x | 34.0x |
| ROIC (TTM) | 32.06% | 15.24% |
| Gross margin | 83.51% | 36.24% |
| Net margin | 34.98% | 16.85% |
| Revenue CAGR 5y | 23.17% | 2.08% |
| EPS CAGR 5y | 40.81% | -6.4% |
| Debt / Equity | 1.4x | 0.1x |
| Dividend yield | 0.64% | 0.29% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- EPS CAGR 5y40.81%vs -6.4%+116%
- Market cap$946.37Bvs $21.21B+98%
- Revenue CAGR 5y23.17%vs 2.08%+91%
- Gross margin83.51%vs 36.24%+57%
WST leads on
- Debt / Equity0.1xvs 1.4x+92%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.